Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Grp LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.20p +0.85% 23.70p 22.60p 24.80p - - - 0 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -2.5 -0.1 - 8.64

Salvarx Grp Share Discussion Threads

Showing 151 to 174 of 175 messages
Chat Pages: 7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
05/5/2018
14:38
Satisfactory end to the week.
fig1
03/5/2018
09:15
No liquidity in the shares. Won't take much buying to get the price above 30p where it should be.
wiseacre
02/5/2018
13:46
Patience Fillipe, patience.
fig1
02/5/2018
13:41
SALV + 18% today, although seems to have dropped off the radars of most folks. f
fillipe
09/4/2018
18:21
Aren't immunotherapy related stocks out of favour right now- given some recent failings in the immunotherapy related process and sector ?
kristini2
05/4/2018
17:17
Actually dexdringle I think the stock is grossly undervalued but as far as the company is concerned it appears not to give a button, in terms of promotion here, and I have heard the American CEO, not only has a contempt for AIM, but, is looking to get the shares quoted his side of the Atlantic where biotech gets a better rating. With regard to my comment on the quality of investors I hardly think the promoter of the company at IPO, Peterhouse, has a great roster of long-term investors to get the stock away. Maybe you are one of them! No offence intended.
wiseacre
04/4/2018
15:39
"wiseacre 22 Mar '18 - 11:22 - 111 of 112 The problem is that those who subscribed at 33p, not the highest quality of investor......." Eh ? Why would investing at 33p not been a sign of being a high quality investor ? Presumably you were a genius and were shorting it from there (and are still doing so) thus making you a very high quality investor ? Unless all investors who buy something that goes down are poor quality investors - in which case please stand up the person who only ever buys things that go up !!
dexdringle
22/3/2018
16:41
well they could, but i'm rather disillusioned with riskier and small cap investing I think you;re better off going to a casino
kristini2
22/3/2018
11:22
The problem is that those who subscribed at 33p, not the highest quality of investor, have lost heart and there could be some tax loss selling, not to mention the fact that the shares have fallen on very low volume. I think Kristin's time horizon is far too pessimistic and the shares could easily double in the blink of an eye.
wiseacre
20/3/2018
18:38
It's fairly illiquid with little volumes period, and so one must be prepared to hold long term, i mean maybe 5 years + I am thinking maybe 10 years It will not take too much given the market cap here to see positive price action, and so the risk reward over 5 years looks good. The speculative nature is a given
kristini2
20/3/2018
16:25
Good point. What I don't understand is why the price peaked at 45p and is now 20p (ish). surely there are not sufficient fickle holders to cause the price to fall and fall. Most must be in it for the long haul. So why the volatility ?
dexdringle
20/3/2018
16:20
Come on dexdringle you should know that biotech has long lead times but with cancer immunotherapy lead times are quicker. If you have no patience you shouldn't be here.
wiseacre
19/3/2018
15:01
....if they could be so kind as to see their way, if it isn't too much trouble, to start MAKING SOME IMPRESSIVE PROFITS then I suspect that we all might become a little more 'enchanted'.......
dexdringle
19/3/2018
10:46
The American management is disenchanted with AIM and, I believe, could be looking at a listing their side of the Atlantic
wiseacre
15/3/2018
23:41
Yep I don't think I'd invest just on Mellon The American angle more interesting
the stigologist
15/3/2018
17:42
You are quite right Stig but this one is led by an American who came out of Bristol Myers Squibb, the leaders in immunotherapy, and has done zilch PR for the company. The company was floated at 33p two years ago and has come a long way since then. Time will tell.
wiseacre
15/3/2018
16:43
Kumo bull break-out today.
blueball
15/3/2018
10:20
maybe it's a good shout on Mellon but I don't think he's regarded as being that good that people would just buy his tips just because he's tipped something he is a bit hit and miss and often times on public listed stuff miss
the stigologist
14/3/2018
16:47
He may mention it or it will appear as part of a portfolio of options on a slide presentation. I hold.
fig1
13/3/2018
10:34
Kumo Bull break-out yesterday.
blueball
12/3/2018
14:42
edit. March 9 2018....180p - Northland reiterated their 180p tp, first mentioned 23-10-2017 although there's been some strong news since that 10/2017 mention. Only 36.47m shares in total here at SALV, so still only a tiny market cap - barely over £10m, even after today's uplift of now abt 29p at the best ask. Cheap. f
fillipe
12/3/2018
10:50
Jim Mellon retweeted this hTtps://twitter.com/greenhamneggs/status/971720358100389888
the stigologist
12/3/2018
10:29
+ 49%....! f
fillipe
12/3/2018
10:22
does look that way
the stigologist
Chat Pages: 7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180523 03:42:16